Annabel Samimy analyst STIFEL

Currently out of the existing stock ratings of Annabel Samimy, 172 are a BUY (81.9%), 38 are a HOLD (18.1%).

Annabel Samimy

Work Performance Price Targets & Ratings Chart

Analyst Annabel Samimy works at STIFEL with a stock forecast success ratio of 51.48% fulfilled within 231 days on average.

Annabel Samimy’s has documented 357 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VKTX, Viking Therapeutics at 14-Feb-2024.

Wall Street Analyst Annabel Samimy

Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for EOLS (EVOLUS) at 1/28/2019. The price target of $27 was fulfilled within 10 days with a profit of $12.01 (80.12%) receiving and performance score of 80.12.

Average potential price target upside

AERI Aerie Pharmaceuticals . AGN Allergan plc ANGN Angion Biomedica Corp CALT Calliditas Therapeutics CARA Cara Therapeutic ENDP Endo International PLC EOLS Evolus EVFM Evofem Biosciences FGEN FibroGen HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC MNK Mallinckrodt plc PRGO Perrigo Company PLC RDUS Schnitzer Steel Industries RETA Reata Pharmaceuticals RVNC Revance The TXMD TherapeuticsMD APLS Apellis Pharmaceuticals BHC Bausch Health Companies CLSD Clearside Biomedical SBBP Strongbridge Biopharma plc SUPN Supernus Pharmaceuticals ISEE IVERIC bio RXDX Prometheus Biosciences ZGNX Zogenix PHAS PhaseBio Pharmaceuticals VKTX Viking Therapeutics RANI Rani Therapeutics Holdings

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



1 years 7 months 24 days ago

1/5 (20%)

$4.7 (56.63%)



1 years 7 months 29 days ago

0/1 (0%)

$6.53 (25.64%)



1 years 7 months 29 days ago

0/4 (0%)

$14.21 (245.42%)




1 years 7 months 30 days ago

7/11 (63.64%)

$0.09 (0.59%)





1 years 7 months 30 days ago

1/3 (33.33%)

$0.09 (0.59%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Annabel Samimy is most bullish on?

Potential upside of $30.19 has been obtained for APLS (APELLIS PHARMACEUTICALS)

Which stock is Annabel Samimy is most reserved on?

Potential downside of -$40.88 has been obtained for VKTX (VIKING THERAPEUTICS)

What Year was the first public recommendation made by Annabel Samimy?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?